| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 733748-92-0 | 4-(3-異丙基-1,2,4-惡二唑-5-基)哌啶 | Piperidine,4-[3-(1-methylethyl)-1,2,4-oxadiazol-5-yl]- |  | C10H17N3O | 詳情 | 供應(yīng)商 |
| 733751-26-3 | 4-(3-異丙基-1,2,4-惡二唑基-5-基)哌啶鹽酸鹽 | 4-(3-ISOPROPYL-1,2,4-OXADIAZOL-5-YL)PIPERIDINE HYDROCHLORIDE | 無(wú) | C10H18ClN3O | 詳情 | 供應(yīng)商 |
| 937174-76-0 | 4-[2-(4-氨基-1,2,5-惡二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-? | 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4; 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol; GSK 690693; (R)-4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-(PIPERIDIN-3-YLMETHOXY)-1H-IMI |  | C21H27N7O3 | 詳情 | 供應(yīng)商 |
| 751-47-3 | 2-(4-氯苯基)-5-(4-哌啶基)-1,3,4-惡二唑; 2-(4-氯苯基)-5-(4-哌啶基)-1,3,4-惡二唑 | 2-(4-Chlorophenyl)-5-(piperidin-4-yl)-1,3,4-oxadiazole | 無(wú) | 詳情 | 供應(yīng)商 |